<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d389">
    <sentence id="DDI-DrugBank.d389.s0" text="Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.">
        <entity id="DDI-DrugBank.d389.s0.e0" charOffset="0-13"
            type="group" text="Antihistamines"/>
        <entity id="DDI-DrugBank.d389.s0.e1" charOffset="42-66"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d389.s0.e2" charOffset="69-80"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d389.s0.e3" charOffset="83-89"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d389.s0.e4" charOffset="102-116"
            type="group" text="CNS depressants"/>
        <ddi id="DDI-DrugBank.d389.s0.d0" e1="DDI-DrugBank.d389.s0.e0"
            e2="DDI-DrugBank.d389.s0.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d389.s0.d1" e1="DDI-DrugBank.d389.s0.e0"
            e2="DDI-DrugBank.d389.s0.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d389.s0.d2" e1="DDI-DrugBank.d389.s0.e0"
            e2="DDI-DrugBank.d389.s0.e3" type="effect"/>
        <ddi id="DDI-DrugBank.d389.s0.d3" e1="DDI-DrugBank.d389.s0.e0"
            e2="DDI-DrugBank.d389.s0.e4" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d389.s1" text="MAO inhibitors prolong and intensify the anticholinergic effects of antihistamines.">
        <entity id="DDI-DrugBank.d389.s1.e0" charOffset="0-13"
            type="group" text="MAO inhibitors"/>
        <entity id="DDI-DrugBank.d389.s1.e1" charOffset="68-81"
            type="group" text="antihistamines"/>
        <ddi id="DDI-DrugBank.d389.s1.d0" e1="DDI-DrugBank.d389.s1.e0"
            e2="DDI-DrugBank.d389.s1.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d389.s2" text="Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.">
        <entity id="DDI-DrugBank.d389.s2.e0" charOffset="0-21"
            type="group" text="Sympathomimetic amines"/>
        <entity id="DDI-DrugBank.d389.s2.e1" charOffset="66-74"
            type="drug" text="reserpine"/>
        <entity id="DDI-DrugBank.d389.s2.e2" charOffset="77-94"
            type="group" text="veratrum alkaloids"/>
        <entity id="DDI-DrugBank.d389.s2.e3" charOffset="97-106"
            type="drug" text="methyldopa"/>
        <entity id="DDI-DrugBank.d389.s2.e4" charOffset="112-123"
            type="drug" text="mecamylamine"/>
        <ddi id="DDI-DrugBank.d389.s2.d0" e1="DDI-DrugBank.d389.s2.e0"
            e2="DDI-DrugBank.d389.s2.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d389.s2.d1" e1="DDI-DrugBank.d389.s2.e0"
            e2="DDI-DrugBank.d389.s2.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d389.s2.d2" e1="DDI-DrugBank.d389.s2.e0"
            e2="DDI-DrugBank.d389.s2.e3" type="effect"/>
        <ddi id="DDI-DrugBank.d389.s2.d3" e1="DDI-DrugBank.d389.s2.e0"
            e2="DDI-DrugBank.d389.s2.e4" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d389.s3" text="Effects of sympathomimetics are increased with MAO inhibitors and beta adrenergic blockers.">
        <entity id="DDI-DrugBank.d389.s3.e0" charOffset="11-26"
            type="group" text="sympathomimetics"/>
        <entity id="DDI-DrugBank.d389.s3.e1" charOffset="47-60"
            type="group" text="MAO inhibitors"/>
        <entity id="DDI-DrugBank.d389.s3.e2" charOffset="66-89"
            type="group" text="beta adrenergic blockers"/>
        <ddi id="DDI-DrugBank.d389.s3.d0" e1="DDI-DrugBank.d389.s3.e0"
            e2="DDI-DrugBank.d389.s3.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d389.s3.d1" e1="DDI-DrugBank.d389.s3.e0"
            e2="DDI-DrugBank.d389.s3.e2" type="effect"/>
    </sentence>
</document>
